Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia

Broad-spectrum antibiotics administered to patients with severe COVID-19 pneumonia pose a risk of infection caused by Clostridioides difficile. This risk is reduced mainly by strict hygiene measures and early de-escalation of antibiotic therapy. Recently, oral vancomycin prophylaxis (OVP) has also b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogdanová, Kateřina, Doubravská, Lenka, Vágnerová, Iva, Hricová, Kristýna, Pudová, Vendula, Röderová, Magdaléna, Papajk, Jan, Uvízl, Radovan, Langová, Kateřina, Kolář, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653967/
https://www.ncbi.nlm.nih.gov/pubmed/34833003
http://dx.doi.org/10.3390/life11111127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653967/
https://www.ncbi.nlm.nih.gov/pubmed/34833003
http://dx.doi.org/10.3390/life11111127

Ejemplares similares